Use of Cell-Penetrating Peptides in Dendritic Cell-Based Vaccination

Overview

Journal Immune Netw

Specialty Allergy & Immunology

Date 2016 Mar 4

PMID 26937230

Citations 25

Authors

Sangho Lim

Ja-Hyun Koo

Je-Min Choi

Affiliations

Soon will be listed here.

Abstract

Cell-penetrating peptides (CPPs) are short amino acids that have been widely used to deliver macromolecules such as proteins, peptides, DNA, or RNA, to control cellular behavior for therapeutic purposes. CPPs have been used to treat immunological diseases through the delivery of immune modulatory molecules in vivo. Their intracellular delivery efficiency is highly synergistic with the cellular characteristics of the dendritic cells (DCs), which actively uptake foreign antigens. DC-based vaccines are primarily generated by pulsing DCs ex vivo with various immunomodulatory antigens. CPP conjugation to antigens would increase DC uptake as well as antigen processing and presentation on both MHC class II and MHC class I molecules, leading to antigen specific CD4(+) and CD8(+) T cell responses. CPP-antigen based DC vaccination is considered a promising tool for cancer immunotherapy due to the enhanced CTL response. In this review, we discuss the various applications of CPPs in immune modulation and DC vaccination, and highlight the advantages and limitations of the current CPP-based DC vaccination.

Citing Articles

Advances and prospects of cell-penetrating peptides in tumor immunotherapy.

Yang D, Liu B, Sha H Sci Rep. 2025; 15(1):3392.

PMID: 39870681 PMC: 11772771. DOI: 10.1038/s41598-025-86130-8.

A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategies.

Agrez M, Chandler C, Thurecht K, Fletcher N, Liu F, Subramaniam G Sci Rep. 2024; 14(1):26737.

PMID: 39501043 PMC: 11538426. DOI: 10.1038/s41598-024-78150-7.

Characterization of novel cell-penetrating peptides derived from the capsid protein of beak and feather disease virus.

Sitinjak M, Chen J, Wang C Virus Res. 2023; 330:199109.

PMID: 37004901 PMC: 10194187. DOI: 10.1016/j.virusres.2023.199109.

Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections.

Khairkhah N, Namvar A, Bolhassani A Mol Biotechnol. 2023; 65(9):1387-1402.

PMID: 36719639 PMC: 9888354. DOI: 10.1007/s12033-023-00679-1.

Cell penetrating peptide: A potent delivery system in vaccine development.

Hasannejad-Asl B, Pooresmaeil F, Takamoli S, Dabiri M, Bolhassani A Front Pharmacol. 2022; 13:1072685.

PMID: 36425579 PMC: 9679422. DOI: 10.3389/fphar.2022.1072685.

References

Saleh A, Aojula H, Arthanari Y, Offerman S, Alkotaji M, Pluen A . Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptide. J Control Release. 2010; 143(2):233-42. DOI: 10.1016/j.jconrel.2009.12.025. View

Arthanari Y, Pluen A, Rajendran R, Aojula H, Demonacos C . Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells. J Control Release. 2010; 145(3):272-80. DOI: 10.1016/j.jconrel.2010.04.011. View

Aarntzen E, Srinivas M, Schreibelt G, Heerschap A, Punt C, Figdor C . Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination. Oncoimmunology. 2013; 2(7):e24661. PMC: 3782158. DOI: 10.4161/onci.24661. View

Park T, Park S, Cho J, Moon J, Kim N, Park K . RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells. Proc Natl Acad Sci U S A. 2014; 111(52):18673-8. PMC: 4284575. DOI: 10.1073/pnas.1413687112. View

Gaestel M . MAPKAP kinases - MKs - two's company, three's a crowd. Nat Rev Mol Cell Biol. 2006; 7(2):120-30. DOI: 10.1038/nrm1834. View

Baeuerle P, Henkel T . Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994; 12:141-79. DOI: 10.1146/annurev.iy.12.040194.001041. View

Tacken P, de Vries I, Torensma R, Figdor C . Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol. 2007; 7(10):790-802. DOI: 10.1038/nri2173. View

Shibagaki N, Udey M . Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J Immunol. 2002; 168(5):2393-401. DOI: 10.4049/jimmunol.168.5.2393. View

Jo D, Liu D, Yao S, Collins R, Hawiger J . Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med. 2005; 11(8):892-8. DOI: 10.1038/nm1269. View

10.

Macian F . NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005; 5(6):472-84. DOI: 10.1038/nri1632. View

11.

Li D, Romain G, Flamar A, Duluc D, Dullaers M, Li X . Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J Exp Med. 2012; 209(1):109-21. PMC: 3260876. DOI: 10.1084/jem.20110399. View

12.

Ramsey J, Flynn N . Cell-penetrating peptides transport therapeutics into cells. Pharmacol Ther. 2015; 154:78-86. DOI: 10.1016/j.pharmthera.2015.07.003. View

13.

Cresswell P, Ackerman A, Giodini A, Peaper D, Wearsch P . Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev. 2005; 207:145-57. DOI: 10.1111/j.0105-2896.2005.00316.x. View

14.

Shen L, Sigal L, Boes M, Rock K . Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity. 2004; 21(2):155-65. DOI: 10.1016/j.immuni.2004.07.004. View

15.

Derossi D, Joliot A, Chassaing G, Prochiantz A . The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem. 1994; 269(14):10444-50. View

16.

Derouazi M, di Berardino-Besson W, Belnoue E, Hoepner S, Walther R, Benkhoucha M . Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity. Cancer Res. 2015; 75(15):3020-31. DOI: 10.1158/0008-5472.CAN-14-3017. View

17.

Choi J, Kim S, Shin J, Gibson T, Yoon B, Lee D . Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis. Proc Natl Acad Sci U S A. 2008; 105(50):19875-80. PMC: 2604944. DOI: 10.1073/pnas.0805198105. View

18.

Zaro J, Vekich J, Tran T, Shen W . Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells. Mol Pharm. 2009; 6(2):337-44. PMC: 3638978. DOI: 10.1021/mp800239p. View

19.

Ivanov I, McKenzie B, Zhou L, Tadokoro C, Lepelley A, Lafaille J . The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006; 126(6):1121-33. DOI: 10.1016/j.cell.2006.07.035. View

20.

Brugnano J, Chan B, Seal B, Panitch A . Cell-penetrating peptides can confer biological function: regulation of inflammatory cytokines in human monocytes by MK2 inhibitor peptides. J Control Release. 2011; 155(2):128-33. DOI: 10.1016/j.jconrel.2011.05.007. View